MedTrace Logo

Clinical Outcomes and Costs of 4-Week Versus 6-Week Bloodwork for Patients on Hemodialysis

NCT03659500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-04-03

No results posted yet for this study

Summary

The objective of this quality improvement study was to determine the effect of an institution-wide switch of routine bloodwork from four-week intervals to six-week intervals on the achievement of anemia and chronic kidney disease-mineral and bone disorder (CKD-MBD) targets for patients on chronic hemodialysis.

Conditions

Interventions

DIAGNOSTIC_TEST

Four-week routine bloodwork

Routine hemodialysis bloodwork done every 4 weeks

DIAGNOSTIC_TEST

Six-week routine bloodwork

Routine hemodialysis bloodwork done every 6 weeks

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • Samuel Silver

    lead OTHER

Principal Investigators

  • Samuel A Silver · Queen's University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-01
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03659500 on ClinicalTrials.gov